Ratings Remedy Entertainment Oyj

Equities

REMEDY

FI4000251897

Delayed Nasdaq Helsinki Other stock markets 11:23:17 10/05/2024 BST			5-day change	1st Jan Change
18.06 ^EUR	-0.11%		-10.15%	-28.90%

05-08	Terhi Kauppi Resigns as Chief Financial Officer of Remedy Entertainment Plc, Effective June 30, 2024	CI
04-29	Transcript : Remedy Entertainment Oyj, Q1 2024 Earnings Call, Apr 29, 2024

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The company is in a robust financial situation considering its net cash and margin position.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Analyst opinion has improved significantly over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

Low profitability weakens the company.
With an enterprise value anticipated at 4.85 times the sales for the current fiscal year, the company turns out to be overvalued.
The company appears highly valued given the size of its balance sheet.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Over the past four months, analysts' average price target has been revised downwards significantly.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
REMEDY ENTERTAINMENT OYJ	-28.90%	264M	-
MICROSOFT CORPORATION	+9.65%	3,064B	C+
SYNOPSYS INC.	+6.79%	83.88B	B
CADENCE DESIGN SYSTEMS, INC.	+4.74%	77.63B	B+
DASSAULT SYSTÈMES SE	-13.73%	53.97B	B+
PALANTIR TECHNOLOGIES INC.	+23.12%	47.08B	D+
ATLASSIAN CORPORATION	-24.39%	46.81B	B-
THE TRADE DESK, INC.	+23.22%	43.34B	D+
SEA LIMITED	+62.94%	37.9B	D+
ROBLOX CORPORATION	-33.46%	19.46B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes